124 related articles for article (PubMed ID: 8182410)
1. Raynaud's phenomenon associated with alpha-interferon therapy.
Arslan M; Ozyilkan E; Kayhan B; Telatar H
J Intern Med; 1994 May; 235(5):503. PubMed ID: 8182410
[No Abstract] [Full Text] [Related]
2. Severe Raynaud's phenomenon with chronic hepatis C disease treated with interferon.
Iorio R; Spagnuolo MI; Sepe A; Zoccali S; Alessio M; Vegnente A
Pediatr Infect Dis J; 2003 Feb; 22(2):195-7. PubMed ID: 12613457
[TBL] [Abstract][Full Text] [Related]
3. Interferon-alpha induced Raynaud's syndrome.
Kruit WH; Eggermont AM; Stoter G
Ann Oncol; 2000 Nov; 11(11):1501-2. PubMed ID: 11142493
[TBL] [Abstract][Full Text] [Related]
4. Interferon-induced Raynaud's syndrome.
Schapira D; Nahir AM; Hadad N
Semin Arthritis Rheum; 2002 Dec; 32(3):157-62. PubMed ID: 12528080
[TBL] [Abstract][Full Text] [Related]
5. Raynaud's phenomenon and digital necrosis induced by interferon-alpha.
Bachmeyer C; Farge D; Gluckman E; Miclea JM; Aractingi S
Br J Dermatol; 1996 Sep; 135(3):481-3. PubMed ID: 8949451
[TBL] [Abstract][Full Text] [Related]
6. Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis.
Georgetson MJ; Yarze JC; Lalos AT; Webster GF; Martin P
Am J Gastroenterol; 1993 Oct; 88(10):1756-8. PubMed ID: 8213720
[TBL] [Abstract][Full Text] [Related]
7. Acrocyanosis induced by interferon alpha(2a).
Campo-Voegeli A; Estrach T; Marti RM; Corominas N; Tuset M; Mascaró JM
Dermatology; 1998; 196(3):361-3. PubMed ID: 9621152
[TBL] [Abstract][Full Text] [Related]
8. The Raynaud phenomenon and interferon therapy.
Creutzig A; Caspary L; Freund M
Ann Intern Med; 1996 Sep; 125(5):423. PubMed ID: 8702103
[No Abstract] [Full Text] [Related]
9. [Raynaud syndrome complicated by digital gangrene during treatment with interferon-alpha].
Liozon E; Delaire L; Lacroix P; Labrousse F; Ly K; Fauchais AL; Loustaud-Ratti V; Vidal J; Liozon F; Vidal E
Rev Med Interne; 1997; 18(4):316-9. PubMed ID: 9161559
[TBL] [Abstract][Full Text] [Related]
10. [Methylphenidate and secondary Raynaud's phenomenon].
Iglesias Otero M; Portela Romero M; Bugarín González R; Ventura Victoria MA
Semergen; 2013 Sep; 39(6):330-4. PubMed ID: 24034762
[TBL] [Abstract][Full Text] [Related]
11. Raynaud's phenomenon and bilateral olecranon bursitis co-existing in a patient with chronic hepatitis B and D treated with pegylated interferon.
Arain SR; Umer TP
J Pak Med Assoc; 2016 Jun; 66(6):768-70. PubMed ID: 27339587
[TBL] [Abstract][Full Text] [Related]
12. [A case from practice (312). Chronic active hepatitis B--nonresponder to interferon therapy].
Stoll A
Praxis (Bern 1994); 1994 Nov; 83(48):1359-60. PubMed ID: 7801008
[No Abstract] [Full Text] [Related]
13. Raynaud's phenomenon of the nipple associated with labetalol use.
McGuinness N; Cording V
J Hum Lact; 2013 Feb; 29(1):17-9. PubMed ID: 23212937
[TBL] [Abstract][Full Text] [Related]
14. Transient blurred vision after interferon for chronic hepatitis C.
Ene L; Géhénot M; Horsmans Y; Detry-Morel M; Geubel AP
Lancet; 1994 Sep; 344(8925):827-8. PubMed ID: 7916109
[No Abstract] [Full Text] [Related]
15. Chemotherapy-induced Raynaud's phenomenon.
Toumbis-Ioannou E; Cohen PR
Cleve Clin J Med; 1994; 61(3):195-9. PubMed ID: 8026062
[TBL] [Abstract][Full Text] [Related]
16. [Interferon therapy of chronic hepatitis B in children].
Pilette C; Calès P
Gastroenterol Clin Biol; 1995 Jan; 19(1):139-42. PubMed ID: 7720983
[No Abstract] [Full Text] [Related]
17. [Interferon is useful in the treatment of chronic hepatitis B].
Vuoristo M
Duodecim; 1991; 107(13):1087-90. PubMed ID: 1365335
[No Abstract] [Full Text] [Related]
18. [Raynaud's phenomenon after chemotherapy. Apropos of 3 cases].
Adoue D; Arlet P; Vilain C; Le Tallec Y; Bonafé JL; de Lafontan B
Ann Dermatol Venereol; 1985; 112(2):151-5. PubMed ID: 2408534
[TBL] [Abstract][Full Text] [Related]
19. Raynaud's phenomenon induced by sulphasalazine.
Reid J; Holt S; Housley E; Sneddon DJ
Postgrad Med J; 1980 Feb; 56(652):106-7. PubMed ID: 6104805
[TBL] [Abstract][Full Text] [Related]
20. [Raynaud's phenomenon following combined cytostatic treatment of malignant testicular tumours].
Scheulen ME; Schmidt CG
Dtsch Med Wochenschr; 1982 Oct; 107(43):1640-4. PubMed ID: 6183087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
